The stock of Predictive Oncology Inc. (NASDAQ:POAI) is now priced at $0.93 and the shares are -0.15 points down or -14.07% lower compared to its previous closing price of $1.08. The stock had 1.891 million contracts set over the past session. POAI shares’ daily volume is compared to its average trading volume at 960746 shares. However, it has a float of 13.4 million and although its performance was -21.36% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the POAI share price recently placing at $0.84 to $1.07. However, some brokerage firms have priced the stock below the average.
The shorts are running away from the Predictive Oncology Inc. stock, with the latest data on short interest released on August 14, 2020, showing that short interest numbers in the POAI shares have declined. Short interest in the stock represents just 2% of its float, but the volume has dropped by -71152. The volume of shorted shares dropped to 268195 from 339347 shares over the last two weeks. The average intraday trading volume has been 994836 shares, which means that days to cover moved to roughly 1.
In the last trading session, Predictive Oncology Inc. (NASDAQ:POAI) dropped by -$0.252 over the week and lost -$0.742 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $6.25. The stock recorded its established 52-week high on 09/30/19.
Since 09/01/20, the stock has traded to a low of $0.84 at -11.62%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of 1.61. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.
Looking at current readings, Predictive Oncology Inc.’s two-week RSI is 22.9. This suggests that the stock is overbought at the moment and that POAI shares’ price movement remains not stable. The stochastic readings are equally revealing at 8.49% meaning the POAI share price is currently in overbought territory.
The technical chart shows that the POAI stock will likely settle at between $1.052 and $1.176 per share. However, if the stock dips below $0.822, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $0.716.
Currently, the stock is trading in the red of MACD, with a reading of -0.0704. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.
The stocks P/S ratio currently stands below the group’s average of 82.7. Predictive Oncology Inc. has its P/E ratio at 1.2, which means that the stock is currently trading at a discount relative to the 4.6 industry average.